Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

SYSMEX-EUROPA

Sysmex Europe designs and produces laboratory and hematology diagnostic solutions, including instruments, reagents, c... read more Featured Products: More products

Download Mobile App




Sysmex Corporation to Acquire Oxford Gene Technology

By LabMedica International staff writers
Posted on 05 Jun 2017
Sysmex Corporation (Kobe, Japan), an in vitro diagnostic company, has entered into an agreement to acquire molecular genetics company, Oxford Gene Technology (OGT; Begbroke, Oxfordshire, U.K).

Sysmex provides clinical laboratory systemization and solutions, including laboratory diagnostics, laboratory automation and clinical information systems. More...
The company is also exploring emerging opportunities in the life science field and aims to leverage its state-of-the-art technologies for cell, gene and protein analysis. OGT provides genetics research solutions to clinical and academic research institutions for high-quality genetic analysis to enable accurate identification and confirmation of the causative variation underlying genetic diseases.

Following its acquisition, OGT will become a wholly owned subsidiary of Sysmex, allowing it to enter the cytogenetics market with the company’s FISH (fluorescence in situ hybridisation) and aCGH (array comparative genomic hybridisation) products. OGT’s innovation and expertise in genetic assays for hematology, solid cancer and rare disease, combined with Sysmex’s expertise in instrument development and in vitro diagnostics will expand the company’s offerings in genomic medicine. For example, the R&D teams from both the companies will collaborate to develop an automated system for FISH testing by combining Sysmex’s automation technology with the high-quality FISH reagent development expertise possessed by OGT. The acquisition will also strengthen Sysmex’s technology base in molecular genetics through OGT’s NGS (next generation sequencing) reagent development capabilities. Moreover, the addition of OGT’s array CGH and NGS capabilities will further expand the opportunities for Sysmex in genetic testing in the field of rare diseases and liquid biopsies.

“We are delighted to become part of such a well-regarded organization and truly believe that the opportunities arising from joining a large global corporation like Sysmex will be transformational for OGT, its employees and customers,” said Professor Sir Edwin Southern, founder of OGT.

“Alongside the exciting product development opportunities already identified, there are a number of beneficial commercial synergies that will expand market access for OGT’s products putting us at the forefront of molecular genetics,” said OGT’s CEO Dr. Mike Evans. “We are looking forward to the next chapter in our development as part of Sysmex.”


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Silver Member
Vitamin D Assay
EZ Vitamin D Assay
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: iStock

AMP 2026 Underscores Molecular Testing’s Role in Precision Medicine for Women’s Health

Advances in molecular diagnostics are creating new opportunities to improve the detection of sexually transmitted infections, identify antibiotic resistance, and assess cancer recurrence risk in women.... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Graphical Abstract (Matthew A Butzler, Jennifer L Reed, Alaina M Olson, et al. Development of a Rapid Automated Point-of-Care Test for Mycobacterium tuberculosis Detection from Tongue Swabs and Sputum Specimens on the DASH® Rapid PCR System, Open Forum Infectious Diseases, 2026; https://doi.org/10.1093/ofid/ofag706)

Point-of-Care Test Detects Tuberculosis from Tongue Swab and Sputum

Tuberculosis remains a major infectious disease challenge, particularly in regions with limited access to diagnostic testing and treatment. Diagnosis can be time-consuming, and collecting sputum samples... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.